{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:31:51Z","timestamp":1782397911140,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtha.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:21:33Z","timestamp":1774052493000},"page":"2303-2316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic review on the design and methodology of the pediatric direct oral anticoagulant clinical trials for thrombosis prevention: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5323-7023","authenticated-orcid":false,"given":"Hilary","family":"Whitworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Betensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukhmi V.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Al-Ghafry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest K.","family":"Amankwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina T.","family":"Biss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Brandao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Holzhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Kiskaddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene L.M.","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Monagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Raffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana","family":"Revel-Vilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sharathkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Sochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia Heleen","family":"van Ommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Male","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.03.011_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-054649","article-title":"The continued rise of venous thromboembolism across US children\u2019s hospitals","volume":"149","author":"O\u2019Brien","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.jtha.2026.03.011_bib2","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","article-title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial","volume":"11","author":"O\u2019Brien","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2026.03.011_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.021765","article-title":"Thromboprophylaxis for children post-fontan procedure: insights from the UNIVERSE study","volume":"10","author":"McCrindle","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2026.03.011_bib4","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jacc.2023.10.010","article-title":"Apixaban for prevention of thromboembolism in pediatric heart disease","volume":"82","author":"Payne","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2026.03.011_bib5","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2022.09.031","article-title":"Edoxaban for thromboembolism prevention in pediatric patients with cardiac disease","volume":"80","author":"Portman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2026.03.011_bib6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jtha.2024.12.035","volume":"23","author":"Betensky","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.011_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jtha.2026.03.011_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jtha.2026.03.011_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ahj.2019.04.009","article-title":"Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post\u2013Fontan procedure: rationale and design of a prospective, randomized trial (the UNIVERSE study)","volume":"213","author":"Pina","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2026.03.011_bib10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1055\/s-0039-1679938","article-title":"PREVAPIX-ALL: apixaban compared to standard of care for prevention of venous thrombosis in paediatric acute lymphoblastic leukaemia (ALL)\u2014rationale and design","volume":"119","author":"O\u2019Brien","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.011_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2019.08.002","article-title":"A Multi-national trial of a direct oral anticoagulant in children with cardiac disease: design and rationale of the SAXOPHONE study","volume":"217","author":"Payne","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2026.03.011_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1017\/S1047951121002523","article-title":"ENNOBLE-ATE trial: an open-label, randomised, multi-centre, observational study of edoxaban for children with cardiac diseases at risk of thromboembolism","volume":"31","author":"Bhatt","year":"2021","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jtha.2026.03.011_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.011_bib18","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.011_bib19","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/j.1538-7836.2011.04433.x","article-title":"Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children","volume":"9","author":"Mitchell","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.011_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jcph.1966","article-title":"Dosing regimen prediction and confirmation with rivaroxaban for thromboprophylaxis in children after the fontan procedure: insights from the phase III UNIVERSE study","volume":"62","author":"Zhu","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2026.03.011_bib21","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(24)01295-9","article-title":"Bayesian statistics for clinical research","volume":"404","author":"Goligher","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.03.011_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jth.14697","article-title":"Comparative validation study of risk assessment models for pediatric hospital-acquired venous thromboembolism","volume":"18","author":"Mahajerin","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.011_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PCC.0000000000002826","article-title":"A new risk assessment model for hospital-acquired venous thromboembolism in critically ill children: a report from the Children\u2019s Hospital-Acquired Thrombosis Consortium","volume":"23","author":"Jaffray","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jtha.2026.03.011_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3324\/haematol.2011.054775","article-title":"Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation","volume":"97","author":"Branchford","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.03.011_bib25","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1538-7836.2012.04779.x","article-title":"Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule","volume":"10","author":"Sharathkumar","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.011_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/pr.2014.198","article-title":"Development of a pediatric-specific clinical probability tool for diagnosis of venous thromboembolism: a feasibility study","volume":"77","author":"Kerlin","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jtha.2026.03.011_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.thromres.2015.04.036","article-title":"Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery","volume":"136","author":"Arlikar","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.03.011_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/PCC.0b013e31823893f5","article-title":"Thrombosis risk factor assessment and implications for prevention in critically ill children","volume":"13","author":"Reiter","year":"2012","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jtha.2026.03.011_bib29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/TA.0000000000001404","article-title":"Evaluation of guidelines for injured children at high risk for venous thromboembolism: a prospective observational study","volume":"82","author":"Landisch","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2026.03.011_bib30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/PCC.0000000000000699","article-title":"Risk factors for venous thromboembolism in pediatric trauma patients and validation of a novel scoring system: the risk of clots in kids with trauma score","volume":"17","author":"Yen","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jtha.2026.03.011_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamasurg.2015.2670","article-title":"A clinical tool for the prediction of venous thromboembolism in pediatric trauma patients","volume":"151","author":"Connelly","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jtha.2026.03.011_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jpeds.2020.09.016","article-title":"Development of a risk model for pediatric hospital-acquired thrombosis: a report from the Children\u2019s Hospital-Acquired Thrombosis Consortium","volume":"228","author":"Jaffray","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.jtha.2026.03.011_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2016.05.015","article-title":"Age at cancer diagnosis, non-O blood group and asparaginase therapy are independently associated with deep venous thrombosis in pediatric oncology patients: a risk model","volume":"144","author":"Spavor","year":"2016","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362600200X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362600200X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:05:35Z","timestamp":1780574735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362600200X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S153878362600200X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.03.011","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review on the design and methodology of the pediatric direct oral anticoagulant clinical trials for thrombosis prevention: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}